Oghuzan Atay, co-founder and CEO of BillionToOne
Precision diagnostics biotech wins newest round of investor backing in bid to facilitate company expansion
Diagnostics firm BillionToOne raised $55 million in a Series B last year in a bid to expand the company, which markets a prenatal screening test …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
